Newsletter

You are here

Animal research, Health

11 - 09 - 2015

Erythropoietin (EPO) and cancer

EPO is a hormone used to treat severe anaemia as it promotes the production of red blood cells. What are the risks associated with this therapy ? Animal models developed during the EPOCAN European project have shown that EPO may delay or encourage the development of tumours.